Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 343

Similar articles for PubMed (Select 20550720)

2.

Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.

Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH.

Bioorg Med Chem. 2007 Oct 15;15(20):6596-607. Epub 2007 Jul 25.

PMID:
17681794
3.

Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.

Eskander MF, Nagykery NG, Leung EY, Khelghati B, Geula C.

Brain Res. 2005 Oct 26;1060(1-2):144-52. Epub 2005 Oct 5.

PMID:
16212945
4.

Structural insight into the inhibition of acetylcholinesterase by 2,3,4, 5-tetrahydro-1, 5-benzothiazepines.

Nawaz SA, Umbreen S, Kahlid A, Ansari FL, Choudhary MI.

J Enzyme Inhib Med Chem. 2008 Apr;23(2):206-12. doi: 10.1080/14756360701533080 .

PMID:
18343905
5.

Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.

Darvesh S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh R, Martin E.

Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. Epub 2007 Jul 6.

PMID:
17681768
6.

Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.

Tasso B, Catto M, Nicolotti O, Novelli F, Tonelli M, Giangreco I, Pisani L, Sparatore A, Boido V, Carotti A, Sparatore F.

Eur J Med Chem. 2011 Jun;46(6):2170-84. doi: 10.1016/j.ejmech.2011.02.071. Epub 2011 Mar 5.

PMID:
21459491
7.

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.

Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, Yu QS, Mamczarz J, Holloway HW, Giordano T, Chen D, Furukawa K, Sambamurti K, Brossi A, Lahiri DK.

Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17213-8. Epub 2005 Nov 7.

8.
9.

Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy.

Choudhary MI, Nawaz SA, Zaheer-ul-Haq, Azim MK, Ghayur MN, Lodhi MA, Jalil S, Khalid A, Ahmed A, Rode BM, Atta-ur-Rahman, Gilani AU, Ahmad VU.

Biochem Biophys Res Commun. 2005 Jul 15;332(4):1171-7.

PMID:
16021692
10.

Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.

Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.

Drugs Aging. 2004;21(7):453-78. Review.

PMID:
15132713
11.

Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines.

Ansari FL, Iftikhar F, Ihsan-Ul-Haq, Mirza B, Baseer M, Rashid U.

Bioorg Med Chem. 2008 Aug 15;16(16):7691-7. doi: 10.1016/j.bmc.2008.07.009. Epub 2008 Jul 9.

PMID:
18650096
12.
13.

A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.

Elsinghorst PW, Härtig W, Goldhammer S, Grosche J, Gütschow M.

Org Biomol Chem. 2009 Oct 7;7(19):3940-6. doi: 10.1039/b909612d. Epub 2009 Jul 17.

PMID:
19763296
14.

Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

Morán MA, Mufson EJ, Gómez-Ramos P.

Acta Neuropathol. 1993;85(4):362-9.

PMID:
8480510
15.

Synthesis, molecular modeling and evaluation of novel N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Aβ aggregation.

Özturan Özer E, Tan OU, Ozadali K, Küçükkılınç T, Balkan A, Uçar G.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):440-3. doi: 10.1016/j.bmcl.2012.11.064. Epub 2012 Nov 28.

PMID:
23273219
18.

Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.

Samadi A, de los Ríos C, Bolea I, Chioua M, Iriepa I, Moraleda I, Bartolini M, Andrisano V, Gálvez E, Valderas C, Unzeta M, Marco-Contelles J.

Eur J Med Chem. 2012 Jun;52:251-62. doi: 10.1016/j.ejmech.2012.03.022. Epub 2012 Mar 30.

PMID:
22503231
19.

Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.

Razavi SF, Khoobi M, Nadri H, Sakhteman A, Moradi A, Emami S, Foroumadi A, Shafiee A.

Eur J Med Chem. 2013 Jun;64:252-9. doi: 10.1016/j.ejmech.2013.03.021. Epub 2013 Mar 18.

PMID:
23644208
20.

Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase.

Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, Renard PY.

Biochem J. 2013 Aug 1;453(3):393-9. doi: 10.1042/BJ20130013.

PMID:
23679855
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk